A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Clinical trial NCT01379534 · COMPLETED

Trial details

NCT number: NCT01379534
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors and Advanced Endometrial Cancer Endometrial Cancer Second-line Treatment VEGF

Start date: 2011-11-01
Primary completion: 2014-03-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.